These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 5405572)

  • 41. Cerebral catecholamine concentration after L-dopa therapy in Parkinson's disease.
    Greer M; Anton AH
    Trans Am Neurol Assoc; 1970; 95():247-8. PubMed ID: 4328099
    [No Abstract]   [Full Text] [Related]  

  • 42. [Treatment of Parkinson's disease by L-DOPA].
    Barbeau A
    Union Med Can; 1969 Feb; 98(2):183-6. PubMed ID: 5773394
    [No Abstract]   [Full Text] [Related]  

  • 43. [L-dopa in the treatment of Parkinson's disease].
    Völler G
    Med Welt; 1970 Jul; 27():1267-8. PubMed ID: 5512643
    [No Abstract]   [Full Text] [Related]  

  • 44. [Administration of L-dopa in Parkinson's syndrome and vitamin B6 metabolism].
    Kuzuya F; Wakita T; Kawahara H
    Nihon Rinsho; 1973 May; 31(5):1108-15. PubMed ID: 4738416
    [No Abstract]   [Full Text] [Related]  

  • 45. [Our experience with the treatment of Parkinson's disease with L-dopa].
    Buscaino GA; Campanella G
    Acta Neurol (Napoli); 1971; 26(1):46-60. PubMed ID: 5553941
    [No Abstract]   [Full Text] [Related]  

  • 46. [Parkinson's disese. Treatment with L-dopa].
    Herskovits E; Matera R
    Prensa Med Argent; 1969 Oct; 56(35):1674-80. PubMed ID: 5399419
    [No Abstract]   [Full Text] [Related]  

  • 47. Mortality in patients with Parkinson's disease treated with dopa.
    Singer RB
    J Insur Med; 1992; 24(2):126-7. PubMed ID: 10148480
    [No Abstract]   [Full Text] [Related]  

  • 48. [L-dopa treatment of Parkinson's disease. Results after one year].
    Dalle Ore G; Da Pian R; Bazzan A; Giombini S; Solero CL; Maschio A
    Sist Nerv; 1970; 22(2):92-8. PubMed ID: 5504562
    [No Abstract]   [Full Text] [Related]  

  • 49. [Electrophysiological control of the peripheral effects of L-dopa in Parkinson's disease].
    Rovetta P
    Sist Nerv; 1970; 22(2):191-5. PubMed ID: 5504556
    [No Abstract]   [Full Text] [Related]  

  • 50. [Parkinson's syndrome. 7. Experiences with L-dopa-treatment].
    Svanborg A
    Lakartidningen; 1970 Oct; 67(42):4827-31. PubMed ID: 5478708
    [No Abstract]   [Full Text] [Related]  

  • 51. [Monosynaptic reflex in patients with Parkinson's disease treated with L-dopa].
    Palao Sánchez A
    Arch Neurobiol (Madr); 1974; 37(1):1-10. PubMed ID: 4838663
    [No Abstract]   [Full Text] [Related]  

  • 52. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
    Schwab RS; England AC
    Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453
    [No Abstract]   [Full Text] [Related]  

  • 53. [Experiences with L-DOPA (Eldopal) treatment of 40 patients with Parkinson's disease].
    Postma JU; Stam FC; Meerlo HJ
    Ned Tijdschr Geneeskd; 1971 Apr; 115(16):701-7. PubMed ID: 5551426
    [No Abstract]   [Full Text] [Related]  

  • 54. [Prolonged treatment of Parkinson's disease with amantadine and L-Dopa].
    Fieschi C; Casacchia M; Nardini M; Reitano N
    Minerva Med; 1971 Oct; 62(82):4040-2. PubMed ID: 5125075
    [No Abstract]   [Full Text] [Related]  

  • 55. [L-Dopa in the treatment of Parkinson's disease].
    Warot P
    Lille Med; 1971; 17():Suppl:329-34. PubMed ID: 5153001
    [No Abstract]   [Full Text] [Related]  

  • 56. L-dopa in Parkinson's disease.
    Cleghorn RA
    Can Med Assoc J; 1970 Jun; 102(13):1410 passim. PubMed ID: 5422440
    [No Abstract]   [Full Text] [Related]  

  • 57. ["Precursor-therapy" with active amines. 2. Treatment of Parkinson's disease by L-5-HTP (L-5-hydroxytryptophan)].
    Sano I; Taniguchi K
    Seishin Shinkeigaku Zasshi; 1971; 73(11):835-9. PubMed ID: 5316906
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of L-dopa treatment on the speech of patients with Parkinson's disease.
    Audelman JU; Hoel RL; Lassman FM
    Neurology; 1970 Apr; 20(4):410-1. PubMed ID: 5535064
    [No Abstract]   [Full Text] [Related]  

  • 59. L-dopa therapy in Parkinson's disease.
    Murray TJ
    N S Med Bull; 1972 Jun; 51(3):67-70. PubMed ID: 4504954
    [No Abstract]   [Full Text] [Related]  

  • 60. [Preliminary observations on the use of intravenous amantadine and of the association of oral amantadine with anticholinergic drugs and with levo-dopa in the treatment of Parkinson's disease].
    Fasano VA; Urciuoli R; Broggi G
    Minerva Med; 1970 Jul; 61(53):2895-903. PubMed ID: 5428170
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.